Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Bioorganic & Medicinal Chemistry Letters|June 29, 2005
Synthesis and SAR of 2-carboxylic acid indoles as inhibitors of plasminogen activator inhibitor-1Baihua Hu, James W Jetter, Jay E Wrobel, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 11, 2006
Modulation of adipose tissue development by pharmacological inhibition of PAI-1David L Crandall, Elaine M Quinet, Soulaf El Ayachi, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Design and synthesis of oxadiazolidinediones as inhibitors of plasminogen activator inhibitor-1Ariamala Gopalsamy, Scott L Kincaid, John W Ellingboe, et al.
Thrombosis and Haemostasis|April 9, 2008
Dose-dependent thrombus resolution due to oral plaminogen activator inhibitor (PAI)-1 inhibition with tiplaxtinin in a rat stenosis model of venous thrombosisSanjiv Baxi, David L Crandall, Thomas R Meier, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 30, 2005
Evaluation of PAI-039 [{1-benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid], a novel plasminogen activator inhibitor-1 inhibitor, in a canine model of coronary artery thrombosisJames K Hennan, Hassan Elokdah, Mauricio Leal, et al.
Thrombosis and Haemostasis|March 10, 2006
Pharmacologic inhibition of platelet vWF-GPIb alpha interaction prevents coronary artery thrombosisJames K Hennan, Robert E Swillo, Gwen A Morgan, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2010
Synthesis and evaluation of azabicyclo[3.2.1]octane derivatives as potent mixed vasopressin antagonistsAimee L Crombie, Thomas M Antrilli, Brandon A Campbell, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 14, 2005
Rotigaptide (ZP123) prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia/reperfusion injury in open-chest dogsJames K Hennan, Robert E Swillo, Gwen A Morgan, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2007
Characterization of the novel P-selectin inhibitor PSI-697 [2-(4-chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[h] quinoline-4-carboxylic acid] in vitro and in rodent models of vascular inflammation and thrombosisPatricia W Bedard, Valerie Clerin, Natalia Sushkova, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 19, 2008
Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascadeJ Steven Jacobsen, Thomas A Comery, Robert L Martone, et al.
Pageof 2